Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study (Q33356515)

26 July 2017

Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study (English)

1 reference

systemic lupus erythematosus

26 July 2017

1 reference

1 reference

1 reference

E. Farrugia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442758

27 September 2022

V. E. Torres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442758

27 September 2022

D. Gastineau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442758

27 September 2022

C. J. Michet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442758

27 September 2022

K. E. Holley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442758

27 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1442758

27 September 2022

publication date

1 November 1992

1 reference

American Journal of Kidney Diseases

26 July 2017

1 reference

26 July 2017

20

1 reference

26 July 2017

5

1 reference

26 July 2017

463-471

1 reference

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Significance of anti-phospholipid antibodies in patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Noninflammatory renal microangiopathy of systemic lupus erythematosus ('lupus vasculitis').

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Lupus glomerulonephritis with thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Renal thrombotic microvascular disease associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Thrombotic Microangiopathic Nephropathy in Scleroderma and Lupus Anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970258-5

7 January 2021

10.1016/S0272-6386(12)70258-5

Identifiers

DOI

1 reference

26 July 2017

1 reference